RESOLV / FDUSD

GIGGLE / USDC

GIGGLE / USDT

GIGGLE / TRY

RESOLV / USDC

RESOLV / TRY

RESOLV / USDT

XNO / BTC

XNO / USDT

ERA / BNB

HMSTR / FDUSD

HMSTR / TRY

HMSTR / USDT

DASH / ETH

DASH / BTC

A2Z / USDC

DASH / USDT

PEOPLE / BTC

A2Z / USDT

ZEN / BTC

KEYNOTE FIN SERV LTD.

KUNDAN EDIFICE LIMITED

SILLY MONKS ENTERTAIN LTD

FONEBOX RETAIL LIMITED

EPPELTONE ENGINEERS LTD

EXXARO TILES LIMITED

ROCKINGDEALS CIRCU ECO L

THANGAMAYIL JEWELLERY LTD

3M INDIA LIMITED

HITACHI ENERGY INDIA LTD

INDIAN EMULSIFERS LTD

FISCHER MEDICAL VENTURE L

CAPITAL TRUST LTD

JAY BEE LAMINATIONS LTD

BLUE JET HEALTHCARE LTD

VEEKAYEM FASH & APP LTD

FINEOTEX CHEMICAL LIMITED

DIGIKORE STUDIOS LIMITED

SPL INDUSTRIES LIMITED

ELEGANZ INTERIORS LIMITED

Click here to get full coverage on DIVISLAB Outlook for the Week - Equitypandit

DIVISLAB Outlook for the Week  Equitypandit

DIVISLAB Outlook for the Week - Equitypandit

Click here to get full coverage on Divi's Laboratories Limited (NSE:DIVISLAB) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - simplywall.st

Divi's Laboratories Limited (NSE:DIVISLAB) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?  simplywall.st

Divi's Laboratories Limited (NSE:DIVISLAB) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - simplywall.st

Click here to get full coverage on India's Divi's Lab jumps on supply agreement, tops pharma index - TradingView

India's Divi's Lab jumps on supply agreement, tops pharma index  TradingView

India's Divi's Lab jumps on supply agreement, tops pharma index - TradingView

Click here to get full coverage on Divi's Laboratories Limited's (NSE:DIVISLAB) Share Price Could Signal Some Risk - simplywall.st

Divi's Laboratories Limited's (NSE:DIVISLAB) Share Price Could Signal Some Risk  simplywall.st

Divi's Laboratories Limited's (NSE:DIVISLAB) Share Price Could Signal Some Risk - simplywall.st

Click here to get full coverage on Divis Lab slides after Q1 PAT falls 18% QoQ to Rs 545 cr - Business Standard

Divis Lab slides after Q1 PAT falls 18% QoQ to Rs 545 cr  Business Standard

Divis Lab slides after Q1 PAT falls 18% QoQ to Rs 545 cr - Business Standard

Click here to get full coverage on Divi’s Laboratories Announces Trading Window Closure - TipRanks

Divi’s Laboratories Announces Trading Window Closure  TipRanks

Divi’s Laboratories Announces Trading Window Closure - TipRanks

Click here to get full coverage on Divis Laboratories Ltd Ranks Among Most Active Stocks with Rs 14,927.06 Lakhs Traded Today - Markets Mojo

Divis Laboratories Ltd Ranks Among Most Active Stocks with Rs 14,927.06 Lakhs Traded Today  Markets Mojo

Divis Laboratories Ltd Ranks Among Most Active Stocks with Rs 14,927.06 Lakhs Traded Today - Markets Mojo

Click here to get full coverage on Divis Laboratories stock jumps 3% as Citi says recent correction is a buying opportunity; 28% upside seen - Moneycontrol

Divis Laboratories stock jumps 3% as Citi says recent correction is a buying opportunity; 28% upside seen  Moneycontrol

Divis Laboratories stock jumps 3% as Citi says recent correction is a buying opportunity; 28% upside seen - Moneycontrol

Click here to get full coverage on Divis Lab and 5 other CDMO stocks to keep on your radar as US Senate passes Biosecure Act - Trade Brains

Divis Lab and 5 other CDMO stocks to keep on your radar as US Senate passes Biosecure Act  Trade Brains

Divis Lab and 5 other CDMO stocks to keep on your radar as US Senate passes Biosecure Act - Trade Brains

Click here to get full coverage on Divis Laboratories shares surge 2.07% amid high volume - TradingView

Divis Laboratories shares surge 2.07% amid high volume  TradingView

Divis Laboratories shares surge 2.07% amid high volume - TradingView

Click here to get full coverage on Divi's Laboratories (NSE:DIVISLAB) shareholders have earned a 17% CAGR over the last five years - simplywall.st

Divi's Laboratories (NSE:DIVISLAB) shareholders have earned a 17% CAGR over the last five years  simplywall.st

Divi's Laboratories (NSE:DIVISLAB) shareholders have earned a 17% CAGR over the last five years - simplywall.st

Click here to get full coverage on Divis Lab inks long-term global pharma deal - Business Standard

Divis Lab inks long-term global pharma deal  Business Standard

Divis Lab inks long-term global pharma deal - Business Standard

Click here to get full coverage on Accumulate Divis Laboratories; target of Rs 6550: Prabhudas Lilladher - TradingView

Accumulate Divis Laboratories; target of Rs 6550: Prabhudas Lilladher  TradingView

Accumulate Divis Laboratories; target of Rs 6550: Prabhudas Lilladher - TradingView

Click here to get full coverage on Divis Lab gains as broker reiterates buy call - Business Standard

Divis Lab gains as broker reiterates buy call  Business Standard

Divis Lab gains as broker reiterates buy call - Business Standard

Click here to get full coverage on Divi's Laboratories Limited (NSE:DIVISLAB) Stock Goes Ex-Dividend In Just Three Days - simplywall.st

Divi's Laboratories Limited (NSE:DIVISLAB) Stock Goes Ex-Dividend In Just Three Days  simplywall.st

Divi's Laboratories Limited (NSE:DIVISLAB) Stock Goes Ex-Dividend In Just Three Days - simplywall.st

Click here to get full coverage on Indian drugmaker Divi's misses June-quarter profit view on weak US pricing - TradingView

Indian drugmaker Divi's misses June-quarter profit view on weak US pricing  TradingView

Indian drugmaker Divi's misses June-quarter profit view on weak US pricing - TradingView

Click here to get full coverage on Divi's Laboratories Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - simplywall.st

Divi's Laboratories Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now  simplywall.st

Divi's Laboratories Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - simplywall.st

Click here to get full coverage on Most Shareholders Will Probably Agree With Divi's Laboratories Limited's (NSE:DIVISLAB) CEO Compensation - simplywall.st

Most Shareholders Will Probably Agree With Divi's Laboratories Limited's (NSE:DIVISLAB) CEO Compensation  simplywall.st

Most Shareholders Will Probably Agree With Divi's Laboratories Limited's (NSE:DIVISLAB) CEO Compensation - simplywall.st

Click here to get full coverage on Divi's Laboratories Insiders Sold ₹620m Of Shares Suggesting Hesitancy - simplywall.st

Divi's Laboratories Insiders Sold ₹620m Of Shares Suggesting Hesitancy  simplywall.st

Divi's Laboratories Insiders Sold ₹620m Of Shares Suggesting Hesitancy - simplywall.st

Click here to get full coverage on With 49% ownership in Divi's Laboratories Limited (NSE:DIVISLAB), insiders continue to have the largest holding even though they have sold shares recently - simplywall.st

With 49% ownership in Divi's Laboratories Limited (NSE:DIVISLAB), insiders continue to have the largest holding even though they have sold shares recently  simplywall.st

With 49% ownership in Divi's Laboratories Limited (NSE:DIVISLAB), insiders continue to have the largest holding even though they have sold shares recently - simplywall.st

Click here to get full coverage on Divis Labs Shares In Focus As Jefferies Upgrades To Buy, Eyes 16% Upside On Sustained Growth Momentum - NDTV Profit

Divis Labs Shares In Focus As Jefferies Upgrades To Buy, Eyes 16% Upside On Sustained Growth Momentum  NDTV Profit

Divis Labs Shares In Focus As Jefferies Upgrades To Buy, Eyes 16% Upside On Sustained Growth Momentum - NDTV Profit

Click here to get full coverage on Divi’s Laboratories Reports Stable Q1 Financial Results for 2025 - TipRanks

Divi’s Laboratories Reports Stable Q1 Financial Results for 2025  TipRanks

Divi’s Laboratories Reports Stable Q1 Financial Results for 2025 - TipRanks

Click here to get full coverage on Divi’s Laboratories Releases Q1 FY2026 Earnings Call Transcript - TipRanks

Divi’s Laboratories Releases Q1 FY2026 Earnings Call Transcript  TipRanks

Divi’s Laboratories Releases Q1 FY2026 Earnings Call Transcript - TipRanks

Click here to get full coverage on Divis Lab Q4 PAT climbs 23% YoY to Rs 662 cr; recommends final dividend of Rs 30/ share - Business Standard

Divis Lab Q4 PAT climbs 23% YoY to Rs 662 cr; recommends final dividend of Rs 30/ share  Business Standard

Divis Lab Q4 PAT climbs 23% YoY to Rs 662 cr; recommends final dividend of Rs 30/ share - Business Standard

Click here to get full coverage on Divis Lab spurts as broker maintains buy call - Business Standard

Divis Lab spurts as broker maintains buy call  Business Standard

Divis Lab spurts as broker maintains buy call - Business Standard

Click here to get full coverage on Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co. - Business Standard

Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co.  Business Standard

Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co. - Business Standard

Click here to get full coverage on Stock Picks: Sagar Doshi suggests Divis Lab, HCL Tech, Marico shares to buy amid Indo-Pak conflict - livemint.com

Stock Picks: Sagar Doshi suggests Divis Lab, HCL Tech, Marico shares to buy amid Indo-Pak conflict  livemint.com

Stock Picks: Sagar Doshi suggests Divis Lab, HCL Tech, Marico shares to buy amid Indo-Pak conflict - livemint.com

Click here to get full coverage on divis lab brokerage bullish triggers for uptrend - Zee Business

divis lab brokerage bullish triggers for uptrend  Zee Business

divis lab brokerage bullish triggers for uptrend - Zee Business

Click here to get full coverage on Divi’s Laboratories Q4 results: PAT surges 26% YoY, revenue up 12% - The Economic Times

Divi’s Laboratories Q4 results: PAT surges 26% YoY, revenue up 12%  The Economic Times

Divi’s Laboratories Q4 results: PAT surges 26% YoY, revenue up 12% - The Economic Times

Click here to get full coverage on Stock Picks Today: Trent, Bajaj Auto, Divis Lab, Lupin On Brokerages Radar - NDTV Profit

Stock Picks Today: Trent, Bajaj Auto, Divis Lab, Lupin On Brokerages Radar  NDTV Profit

Stock Picks Today: Trent, Bajaj Auto, Divis Lab, Lupin On Brokerages Radar - NDTV Profit

Click here to get full coverage on Divis Laboratories Ltd Ranks Among Most Active Stocks with Rs 24,400.43 Lakhs Traded Today - Markets Mojo

Divis Laboratories Ltd Ranks Among Most Active Stocks with Rs 24,400.43 Lakhs Traded Today  Markets Mojo

Divis Laboratories Ltd Ranks Among Most Active Stocks with Rs 24,400.43 Lakhs Traded Today - Markets Mojo

Click here to get full coverage on Divi's Laboratories Q1 Results: Stock falls after profit, margins miss estimates - CNBC TV18

Divi's Laboratories Q1 Results: Stock falls after profit, margins miss estimates  CNBC TV18

Divi's Laboratories Q1 Results: Stock falls after profit, margins miss estimates - CNBC TV18

Click here to get full coverage on Divis Laboratories Ltd Sees Rs 63.52 Crores in Total Traded Value Today - Markets Mojo

Divis Laboratories Ltd Sees Rs 63.52 Crores in Total Traded Value Today  Markets Mojo

Divis Laboratories Ltd Sees Rs 63.52 Crores in Total Traded Value Today - Markets Mojo

Click here to get full coverage on Citi raises its price target on its top pharma pick, sees a 19% upside on the stock - CNBC TV18

Citi raises its price target on its top pharma pick, sees a 19% upside on the stock  CNBC TV18

Citi raises its price target on its top pharma pick, sees a 19% upside on the stock - CNBC TV18

Click here to get full coverage on Wave Outlook – NSE NIFTY & DIVISLAB - Moneymunch

Wave Outlook – NSE NIFTY & DIVISLAB  Moneymunch

Wave Outlook – NSE NIFTY & DIVISLAB - Moneymunch

Click here to get full coverage on Divi's Lab inks supply pact with global pharmaceutical entity - The Economic Times

Divi's Lab inks supply pact with global pharmaceutical entity  The Economic Times

Divi's Lab inks supply pact with global pharmaceutical entity - The Economic Times

Click here to get full coverage on Divi’s Labs Q4 Results: Profit up 23% YoY, beats estimates; declares ₹30 dividend - CNBC TV18

Divi’s Labs Q4 Results: Profit up 23% YoY, beats estimates; declares ₹30 dividend  CNBC TV18

Divi’s Labs Q4 Results: Profit up 23% YoY, beats estimates; declares ₹30 dividend - CNBC TV18

Click here to get full coverage on Divis Laboratories Sees 13.05% Rise in Open Interest Amid Increased Trading Activity - Markets Mojo

Divis Laboratories Sees 13.05% Rise in Open Interest Amid Increased Trading Activity  Markets Mojo

Divis Laboratories Sees 13.05% Rise in Open Interest Amid Increased Trading Activity - Markets Mojo

Click here to get full coverage on Divi’s Laboratories Q1 Results: Cons net profit rises 27% YoY to Rs 545 crore, revenue up 14% - The Economic Times

Divi’s Laboratories Q1 Results: Cons net profit rises 27% YoY to Rs 545 crore, revenue up 14%  The Economic Times

Divi’s Laboratories Q1 Results: Cons net profit rises 27% YoY to Rs 545 crore, revenue up 14% - The Economic Times

Click here to get full coverage on Divis Laboratories Sees 14.91% Surge in Open Interest to 45,151 Contracts - Markets Mojo

Divis Laboratories Sees 14.91% Surge in Open Interest to 45,151 Contracts  Markets Mojo

Divis Laboratories Sees 14.91% Surge in Open Interest to 45,151 Contracts - Markets Mojo

Click here to get full coverage on NSE DIVISLAB – Will Price Hit the Final Target? - Moneymunch

NSE DIVISLAB – Will Price Hit the Final Target?  Moneymunch

NSE DIVISLAB – Will Price Hit the Final Target? - Moneymunch

Click here to get full coverage on Divi’s Lab shares up 3% after Q4 PAT surges 26% YoY. Should you invest? - The Economic Times

Divi’s Lab shares up 3% after Q4 PAT surges 26% YoY. Should you invest?  The Economic Times

Divi’s Lab shares up 3% after Q4 PAT surges 26% YoY. Should you invest? - The Economic Times

Click here to get full coverage on NSE ONGC, DIVISLAB & UPL – Trading Insight - Moneymunch

NSE ONGC, DIVISLAB & UPL – Trading Insight  Moneymunch

NSE ONGC, DIVISLAB & UPL – Trading Insight - Moneymunch

Click here to get full coverage on Divis Labs Share Price Highlights: Divis Labs Stock Price History - The Economic Times

Divis Labs Share Price Highlights: Divis Labs Stock Price History  The Economic Times

Divis Labs Share Price Highlights: Divis Labs Stock Price History - The Economic Times

Click here to get full coverage on Divi's Labs Q3 Results: Cons PAT jumps 64% YoY to Rs 589 crore, revenue up 25% - The Economic Times

Divi's Labs Q3 Results: Cons PAT jumps 64% YoY to Rs 589 crore, revenue up 25%  The Economic Times

Divi's Labs Q3 Results: Cons PAT jumps 64% YoY to Rs 589 crore, revenue up 25% - The Economic Times

Click here to get full coverage on Divi’s Laboratories shares rally 6% on strong Q4 show; should you buy, sell or hold? - Moneycontrol

Divi’s Laboratories shares rally 6% on strong Q4 show; should you buy, sell or hold?  Moneycontrol

Divi’s Laboratories shares rally 6% on strong Q4 show; should you buy, sell or hold? - Moneycontrol

Click here to get full coverage on Divi's Lab stock slips on US supply worries - The Economic Times

Divi's Lab stock slips on US supply worries  The Economic Times

Divi's Lab stock slips on US supply worries - The Economic Times

Click here to get full coverage on Divi's Labs shares up 6% after Q3 PAT jumps 64% YoY. Should you buy, sell, or hold? - The Economic Times

Divi's Labs shares up 6% after Q3 PAT jumps 64% YoY. Should you buy, sell, or hold?  The Economic Times

Divi's Labs shares up 6% after Q3 PAT jumps 64% YoY. Should you buy, sell, or hold? - The Economic Times

Click here to get full coverage on Divi’s Labs Q1FY26 PAT Jumps 26.7% to ₹545 Cr - HDFC Sky

Divi’s Labs Q1FY26 PAT Jumps 26.7% to ₹545 Cr  HDFC Sky

Divi’s Labs Q1FY26 PAT Jumps 26.7% to ₹545 Cr - HDFC Sky

Click here to get full coverage on Divi's Laboratories shares slip 6% in trade; what's worrying investors? - Business Standard

Divi's Laboratories shares slip 6% in trade; what's worrying investors?  Business Standard

Divi's Laboratories shares slip 6% in trade; what's worrying investors? - Business Standard

Click here to get full coverage on Top stock recommendations for January 21, 2025 - Times of India

Top stock recommendations for January 21, 2025  Times of India

Top stock recommendations for January 21, 2025 - Times of India

Click here to get full coverage on Anil Singhvi's Stock Strategy Revealed, Divis Lab, Eternal Futures Target, Stoploss Inside - Zee Business

Anil Singhvi's Stock Strategy Revealed, Divis Lab, Eternal Futures Target, Stoploss Inside  Zee Business

Anil Singhvi's Stock Strategy Revealed, Divis Lab, Eternal Futures Target, Stoploss Inside - Zee Business

Click here to get full coverage on Divi's Laboratories Q3 net profit up 64.5% to ₹589 crore, revenue rises 25% - Upstox

Divi's Laboratories Q3 net profit up 64.5% to ₹589 crore, revenue rises 25%  Upstox

Divi's Laboratories Q3 net profit up 64.5% to ₹589 crore, revenue rises 25% - Upstox

Click here to get full coverage on Divi's Labs hits record high after Citi initiates 'buy' call with most bullish price target - Moneycontrol

Divi's Labs hits record high after Citi initiates 'buy' call with most bullish price target  Moneycontrol

DIVISLAB

Price Chart

Key Statistics

Technicals

About DIVISLAB

Latest News

DIVISLAB Outlook for the Week - Equitypandit

Divi's Laboratories Limited (NSE:DIVISLAB) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - simplywall.st

India's Divi's Lab jumps on supply agreement, tops pharma index - TradingView

Advanced Charts

Top Gainers

Top Losers